<h1>Rights issue approval enables existing shareholders to subscribe to new equity to fund expansion and R&D.</h1> Approval by the Bombay Stock Exchange authorises Remedium Lifecare Limited to proceed with a rights issue of fully paid equity shares offered to existing shareholders on the specified record date, at the stated issue price and rights ratio, enabling subscription and allotment to raise capital for working capital, R&D equipment and manufacturing expansion.